As frustration mounts in places such as Germany with what is perceived as a slow and inefficient vaccine rollout, calls […]
The Unseen Capital Health Fund LP, a newly-formed venture fund created by racially diverse and historically unrepresented business leaders was […]
Although there has been considerable buzz around the recent U.S. Food and Drug Administration (FDA) acceptance of Eli Lilly’s monoclonal […]
The medical and research establishments certainly have given their best during this pandemic. Eli Lilly is no exception, having marshalled […]
Back in late January, a British artificial intelligence (AI) venture known as BenevolentAI was employed to investigate thousands of potential drug […]
The U.S. Food and Drug Administration (FDA), not the clinical sponsor, paused a recent study based on serious quality control […]
The ACTIV-3 clinical trial is being run by the National Institute of Allergy and Infectious Diseases (NIAID), part of the […]
The ACTIV-3 clinical trial, funded by the National Institute of Allergy and Infectious Diseases (NIAID) and a large group of […]
